View Author
plaque patient circulation factor disease heart university blood death study medicine expression aml cell lines event artery center syndrome department research figure cardiology atherosclerosi thrombosis promoter atherosclerotic risk factors technique vulnerability infarction rar ␣2 promoter coll cardiol school rupture inflammation intravascular assessment marker imaging sample institute table risk assessment strategies myocardium level protein artery disease hospital cardiol noninvasive methylation naghavi future atherosclerotic plaques association division lesion method resonance imaging laboratory fuster v number culprit intravascular ultrasound leukemia development stenosi retinoic acid receptor ultrasound retinoic result j cardiol plaque rupture thrombu detection aml cells heart disease consensus document risk assessment rar ␣2 expression tomography
3 Most Recent Publications
|
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
(Article)
Glasow, A. Barrett, A. Enver, T. Hildebrandt, G. Zelent, A. Petrie, K. Gupta, R. Boix-Chornet, M. Zhou, D.C. Grimwade, D. Gallagher, R. Lindern, M.M. von Waxman, S. |
2008-02-15
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-14
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-07
|
